Gpm Growth Investors, Inc. Edwards Lifesciences Corp Transaction History

Gpm Growth Investors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	SELL	$69.28 - $93.38 $431,752 - $581,944	-6,232 Reduced 24.42%	19,291 $1.34 Million
Q2 2023 Jul 28, 2023	SELL	$81.41 - $94.33 $2,849 - $3,301	-35 Reduced 0.14%	25,523 $2.41 Million
Q1 2023 Apr 11, 2023	SELL	$74.26 - $84.51 $27,401 - $31,184	-369 Reduced 1.42%	25,558 $2.11 Million
Q4 2022 Jan 10, 2023	SELL	$68.3 - $87.44 $11,952 - $15,302	-175 Reduced 0.67%	25,927 $0
Q3 2022 Oct 12, 2022	SELL	$82.37 - $107.29 $5,518 - $7,188	-67 Reduced 0.26%	26,102 $2.16 Million
Q2 2022 Jul 12, 2022	BUY	$86.5 - $128.27 $7,525 - $11,159	87 Added 0.33%	26,169 $2.49 Million
Q1 2022 Apr 11, 2022	BUY	$101.96 - $128.34 $2.66 Million - $3.35 Million	26,082 New	26,082 $3.07 Million

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Gpm Growth Investors, Inc., based on Form 13F filings with the SEC.

Stay updated on Gpm Growth Investors, Inc. with notifications on news.